Patterns of ovulation and bleeding with a low levonorgestrel-releasing intrauterine device
CG Nilsson, P Lähteenmäki, T Luukkainen - Contraception, 1980 - Elsevier
Patterns of bleeding and plasma concentrations of levonorgestrel, progesterone, estradiol,
LH and FSH were studied in ten volunteers who had a levonorgestrel-releasing IUD inserted …
LH and FSH were studied in ten volunteers who had a levonorgestrel-releasing IUD inserted …
CCR5 expression levels in HIV-uninfected women receiving hormonal contraception
G Sciaranghella, C Wang, H Hu… - The Journal of …, 2015 - academic.oup.com
Human immunodeficiency virus (HIV) infectivity increases as receptor/coreceptor expression
levels increase. We determined peripheral CD4, CCR5, and CXCR4 expression levels in …
levels increase. We determined peripheral CD4, CCR5, and CXCR4 expression levels in …
Effects of tobacco smoking and oral contraceptive use on theophylline disposition.
MJ Gardner, KM Tornatore, WJ Jusko… - British journal of …, 1983 - Wiley Online Library
The independent as well as interactive effects of chronic (greater than 6 months) oral
contraceptive (OC) use and cigarette smoking on single‐dose (4 mg/kg) theophylline …
contraceptive (OC) use and cigarette smoking on single‐dose (4 mg/kg) theophylline …
A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids
FZ Stanczyk, PF Brenner, DR Mishell Jr, A Ortiz… - Contraception, 1978 - Elsevier
A sensitive and reliable radioimmunoassay (RIA) for the measurement of norethindrone
(NET) in serum has been established employing anti-11α,-hydroxynorethindrone 11 …
(NET) in serum has been established employing anti-11α,-hydroxynorethindrone 11 …
Levonorgestrel in milk and plasma of breast-feeding women with a levonorgestrel-releasing IUD
M Heikkilä, M Haukkamaa, T Luukkainen - Contraception, 1982 - Elsevier
A levonorgestrel-releasing intrauterine contraceptive device was used by 10 breast-feeding
women beginning 6 weeks after delivery. Two models of IUD were used. One released 10 …
women beginning 6 weeks after delivery. Two models of IUD were used. One released 10 …
Levonorgestrel and estradiol release from an improved contraceptive vaginal ring
TM Jackanicz - Contraception, 1981 - Elsevier
A contraceptive vaginal ring containing levonorgestrel and estradiol was designed in which
the drug is located in a 0.15-mm layer beneath a 0.25-mm overcoat at the ring's surface …
the drug is located in a 0.15-mm layer beneath a 0.25-mm overcoat at the ring's surface …
First week drug concentrations in women with levonorgestrel rod or Norplant® capsule implants
I Sivin, P Lähteenmäki, DR Mishell Jr, F Alvarez, S Diaz… - Contraception, 1997 - Elsevier
Forty-two healthy women volunteered to have blood samples drawn at 2, 4, 8, 24, 48, and
168 h (7 days) following placement of levonorgestrel-releasing rod (LNG rod) or of …
168 h (7 days) following placement of levonorgestrel-releasing rod (LNG rod) or of …
Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone
U Goebelsmann, FZ Stanczyk, PF Brenner… - Contraception, 1979 - Elsevier
Abstract Serum norethindrone (NET), FSH, LH, estradiol (E 2) and progesterone (P)
concentrations were measured in 15 women twice weekly for 4 to 6 months following …
concentrations were measured in 15 women twice weekly for 4 to 6 months following …
Duration of breast-feeding and development of children after insertion of a levonorgestrel-releasing intrauterine contraceptive device
M Heikkilä, T Luukkainen - Contraception, 1982 - Elsevier
IUDs releasing levonorgestrel, 10 μg per day (30 patients) and 30 μg per day (40 patients),
and copper-releasing IUDs (Nova-T)(40 patients) were inserted six weeks after delivery in …
and copper-releasing IUDs (Nova-T)(40 patients) were inserted six weeks after delivery in …
Plasma levonorgestrel levels and ovarian function during the use of a levonorgestrel-releasing intracervical contraceptive device
K Ratsula, J Toivonen, P Lähteenmäki, T Luukkainen - Contraception, 1989 - Elsevier
Levonorgestrel, estradiol and progesterone plasma concentrations were measured over four
years of use of a 20 μg/day levonorgestrel-releasing intracervical device (LNG-ICD). The …
years of use of a 20 μg/day levonorgestrel-releasing intracervical device (LNG-ICD). The …